AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $122,000 | +100.0% | 37,000 | +37.0% | 0.00% | – |
| Q2 2018 | $61,000 | -4.7% | 27,000 | +22.7% | 0.00% | – |
| Q1 2018 | $64,000 | +93.9% | 22,000 | +83.3% | 0.00% | – |
| Q4 2017 | $33,000 | -35.3% | 12,000 | -14.3% | 0.00% | – |
| Q3 2017 | $51,000 | +537.5% | 14,000 | +40.0% | 0.00% | – |
| Q4 2014 | $8,000 | -50.0% | 10,000 | -33.5% | 0.00% | – |
| Q3 2014 | $16,000 | – | 15,036 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |